Announcements Trials
Browse Landscape

Status

Completed 48Recruiting 19Terminated 14Unknown 10Active not recruiting 6Not yet recruiting 4Withdrawn 2Suspended 1Enrolling by invitation 1Available 1Approved for marketing 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 27Genitourinary 6Gastrointestinal 5Breast 5Lymphoid 4Thoracic 3Other 3Head & Neck 3Gynecologic 3CNS 3Sarcoma 2Other hematologic neoplasm 2Dermatologic 2Myeloid 1Endocrine 1Classical hematology 1

Conditions

Neuroendocrine Tumors 5Pheochromocytoma 4Pituitary Neoplasms 3Paraganglioma 3Multiple Endocrine Neoplasia Type 1 3Hyperaldosteronism 2Epilepsy 2Diabetes Mellitus 2Carcinoma, Neuroendocrine 2Breast Neoplasms 2Adrenal Gland Neoplasms 2von Willebrand Disease, Type 3 1beta-Thalassemia 1Xanthomatosis, Cerebrotendinous 1X-Linked Combined Immunodeficiency Diseases 1Wolman Disease 1Waardenburg syndrome type 2A 1Waardenburg syndrome type 2 1Waardenburg Syndrome 1VLCAD deficiency 1Usher syndrome, type 1F 1Usher syndrome, type 1C 1Usher syndrome, type 1B 1Tyrosinemias 1Tuberous Sclerosis 2 1Tuberous Sclerosis 1 1Trifunctional Protein Deficiency With Myopathy And Neuropathy 1Thyroid Neoplasms 1Thyroid Dyshormonogenesis 6 1Thyroid Dyshormonogenesis 5 1

Interventions

somapacitan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Neoplasms × Endocrine × Clear all
NCT06709040 2026-04-06

A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters

Novo Nordisk A/S

Enrolling by invitation
500 enrolled
Endocrine

Diabetes Mellitus, Type 2, Dwarfism, Pituitary, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡